Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
Johanna C. Bendell, Valérie André, Alan L. Ho, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 9, pp. 2082-2091
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
Joseph Clara, Cecilia Monge, Yingzi Yang, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 4, pp. 204-232
Closed Access | Times Cited: 623
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 328
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 91
Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies
Junjun Jing, Zhuoxuan Wu, Jiahe Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
The strategies to cure cancer patients by eradicating cancer stem-like cells
Yansui Mai, Jiyan Su, Chuan Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Hedgehog signaling inhibitors in solid and hematological cancers
Jorge E. Cortés, Ralf Gutzmer, Mark W. Kieran, et al.
Cancer Treatment Reviews (2019) Vol. 76, pp. 41-50
Open Access | Times Cited: 109
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Masaru Katoh
Clinical Science (2019) Vol. 133, Iss. 8, pp. 953-970
Closed Access | Times Cited: 91
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer
Richard L. Carpenter, Haimanti Ray
Drug Safety (2019) Vol. 42, Iss. 2, pp. 263-279
Open Access | Times Cited: 87
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
Elisabeth Peer, Suzana Tesanovic, Fritz Aberger
Cancers (2019) Vol. 11, Iss. 4, pp. 538-538
Open Access | Times Cited: 86
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
Advances in Therapy (2022) Vol. 39, Iss. 3, pp. 1164-1178
Open Access | Times Cited: 55
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 15
Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities
Stefano Sol, Fabiana Boncimino, Kristina Todorova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7056-7056
Open Access | Times Cited: 10
Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma
Ralf Gutzmer, James Solomon
Targeted Oncology (2019) Vol. 14, Iss. 3, pp. 253-267
Closed Access | Times Cited: 73
Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia
Catriona Jamieson, Giovanni Martinelli, Cristina Papayannidis, et al.
Blood Cancer Discovery (2020) Vol. 1, Iss. 2, pp. 134-145
Open Access | Times Cited: 56
Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives
Daniel M. Girardi, Adriana Barrichello, Gustavo dos Santos Fernandes, et al.
Cells (2019) Vol. 8, Iss. 2, pp. 153-153
Open Access | Times Cited: 53
Synthesis of Axially Chiral CF3‐Substituted 2‐Arylpyrroles by Sequential Phosphine‐Catalyzed Asymmetric [3+2] Annulation and Oxidative Central‐to‐Axial Chirality Transfer
Chuan Xiang Alvin Tan, Rui Li, Fuhao Zhang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 47
Closed Access | Times Cited: 28
Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
Olivia Chen, Keemberly Kim, Chelsea Steele, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3720-3720
Open Access | Times Cited: 24
Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention
Beena Thazhackavayal Baby, Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 754, pp. 109952-109952
Open Access | Times Cited: 6
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
Silvia Pietrobono, Barbara Stecca
Cells (2018) Vol. 7, Iss. 12, pp. 272-272
Open Access | Times Cited: 41
The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma
Rupesh Jain, Sunil Kumar Dubey, Gautam Singhvi
Drug Discovery Today (2021) Vol. 27, Iss. 4, pp. 1176-1183
Closed Access | Times Cited: 28
Identification, Culture and Targeting of Cancer Stem Cells
Alejandro Herreros‐Pomares
Life (2022) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 22
Update on immune‐based therapy strategies targeting cancer stem cells
Amirhossein Izadpanah, Niloufar Mohammadkhani, Mina Masoudnia, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18960-18980
Open Access | Times Cited: 13
Personalized Systemic Therapies in Hereditary Cancer Syndromes
Luciana Mastrodomenico, Claudia Piombino, Beatrice Riccò, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 684-684
Open Access | Times Cited: 11
Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway
Mengli Zhang, Shijie Tan, Di Yu, et al.
Toxicology and Applied Pharmacology (2019) Vol. 365, pp. 1-8
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top